Knowledge, Attitude, and Risk Perception in Oral Isotretinoin Use: A Cross-Sectional Study from Jordan
The most prevalent skin condition is acne vulgaris. Recent clinical practice guidelines recommend oral isotretinoin to treat moderate-to-severe acne. The aim of this study is to assess the knowledge, attitude, and risk perception of oral isotretinoin for acne treatment. This is a cross-sectional des...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Dermatology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2024/7714527 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849414322573279232 |
|---|---|
| author | Mai I. Al-Hawamdeh Mariam Al-Ameri Salli Lutfi Nidal Muhtaseb Rasha Takhayneh Tasneem Awamreh |
| author_facet | Mai I. Al-Hawamdeh Mariam Al-Ameri Salli Lutfi Nidal Muhtaseb Rasha Takhayneh Tasneem Awamreh |
| author_sort | Mai I. Al-Hawamdeh |
| collection | DOAJ |
| description | The most prevalent skin condition is acne vulgaris. Recent clinical practice guidelines recommend oral isotretinoin to treat moderate-to-severe acne. The aim of this study is to assess the knowledge, attitude, and risk perception of oral isotretinoin for acne treatment. This is a cross-sectional descriptive study conducted in the country of Jordan. The study sample includes people resident in Jordan aged ≥14 years who have been treated with oral isotretinoin for acne. The study involved 373 participants who previously used oral isotretinoin for skin disorders. Most were Jordanian (89.3%), aged 19–25 (37.3%), and from the central region (82.8%). Mostly, they used isotretinoin for severe or mild acne (25.2% and 24.1%, respectively), rosacea (4.1%), or to alleviate acne scars. Surprisingly, 58.1% did not consult their specialist for side effects, and 20% shared their treatment. The average proper use score was 9.98 out of 16. A link was found between higher risk knowledge scores and proper use scores. Side effects such as nausea, irregular heartbeat, and pancreatitis affected some users (11.5%, 10.5%, 7.0%, and 3.2%, respectively). Knowledge about isotretinoin’s risks varied, with percentages recognizing teratogenicity (57.7%), liver damage (52.6%), and lipid profile effects (37.2%), while 25% believed that they had no side effects. The study revealed partial adherence to oral isotretinoin guidelines, with gaps in monitoring and consultation. A positive correlation emerged between risk knowledge and proper usage, emphasizing the need for comprehensive education and monitoring strategies in isotretinoin therapy for skin disorders. |
| format | Article |
| id | doaj-art-6d7192ff589f4b71bb3fc733982c4a54 |
| institution | Kabale University |
| issn | 1687-6113 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Dermatology Research and Practice |
| spelling | doaj-art-6d7192ff589f4b71bb3fc733982c4a542025-08-20T03:33:52ZengWileyDermatology Research and Practice1687-61132024-01-01202410.1155/2024/7714527Knowledge, Attitude, and Risk Perception in Oral Isotretinoin Use: A Cross-Sectional Study from JordanMai I. Al-Hawamdeh0Mariam Al-Ameri1Salli Lutfi2Nidal Muhtaseb3Rasha Takhayneh4Tasneem Awamreh5College of PharmacyFaculty of PharmacyCollege of PharmacyCollege of PharmacyCollege of PharmacyCollege of PharmacyThe most prevalent skin condition is acne vulgaris. Recent clinical practice guidelines recommend oral isotretinoin to treat moderate-to-severe acne. The aim of this study is to assess the knowledge, attitude, and risk perception of oral isotretinoin for acne treatment. This is a cross-sectional descriptive study conducted in the country of Jordan. The study sample includes people resident in Jordan aged ≥14 years who have been treated with oral isotretinoin for acne. The study involved 373 participants who previously used oral isotretinoin for skin disorders. Most were Jordanian (89.3%), aged 19–25 (37.3%), and from the central region (82.8%). Mostly, they used isotretinoin for severe or mild acne (25.2% and 24.1%, respectively), rosacea (4.1%), or to alleviate acne scars. Surprisingly, 58.1% did not consult their specialist for side effects, and 20% shared their treatment. The average proper use score was 9.98 out of 16. A link was found between higher risk knowledge scores and proper use scores. Side effects such as nausea, irregular heartbeat, and pancreatitis affected some users (11.5%, 10.5%, 7.0%, and 3.2%, respectively). Knowledge about isotretinoin’s risks varied, with percentages recognizing teratogenicity (57.7%), liver damage (52.6%), and lipid profile effects (37.2%), while 25% believed that they had no side effects. The study revealed partial adherence to oral isotretinoin guidelines, with gaps in monitoring and consultation. A positive correlation emerged between risk knowledge and proper usage, emphasizing the need for comprehensive education and monitoring strategies in isotretinoin therapy for skin disorders.http://dx.doi.org/10.1155/2024/7714527 |
| spellingShingle | Mai I. Al-Hawamdeh Mariam Al-Ameri Salli Lutfi Nidal Muhtaseb Rasha Takhayneh Tasneem Awamreh Knowledge, Attitude, and Risk Perception in Oral Isotretinoin Use: A Cross-Sectional Study from Jordan Dermatology Research and Practice |
| title | Knowledge, Attitude, and Risk Perception in Oral Isotretinoin Use: A Cross-Sectional Study from Jordan |
| title_full | Knowledge, Attitude, and Risk Perception in Oral Isotretinoin Use: A Cross-Sectional Study from Jordan |
| title_fullStr | Knowledge, Attitude, and Risk Perception in Oral Isotretinoin Use: A Cross-Sectional Study from Jordan |
| title_full_unstemmed | Knowledge, Attitude, and Risk Perception in Oral Isotretinoin Use: A Cross-Sectional Study from Jordan |
| title_short | Knowledge, Attitude, and Risk Perception in Oral Isotretinoin Use: A Cross-Sectional Study from Jordan |
| title_sort | knowledge attitude and risk perception in oral isotretinoin use a cross sectional study from jordan |
| url | http://dx.doi.org/10.1155/2024/7714527 |
| work_keys_str_mv | AT maiialhawamdeh knowledgeattitudeandriskperceptioninoralisotretinoinuseacrosssectionalstudyfromjordan AT mariamalameri knowledgeattitudeandriskperceptioninoralisotretinoinuseacrosssectionalstudyfromjordan AT sallilutfi knowledgeattitudeandriskperceptioninoralisotretinoinuseacrosssectionalstudyfromjordan AT nidalmuhtaseb knowledgeattitudeandriskperceptioninoralisotretinoinuseacrosssectionalstudyfromjordan AT rashatakhayneh knowledgeattitudeandriskperceptioninoralisotretinoinuseacrosssectionalstudyfromjordan AT tasneemawamreh knowledgeattitudeandriskperceptioninoralisotretinoinuseacrosssectionalstudyfromjordan |